DeliKet (Substudy of KetoNiFast Study ID 22-1398_1)

NCT ID: NCT06535022

Last Updated: 2024-08-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-01

Study Completion Date

2026-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Postoperative delirium is a common problem of the critically ill patient and associated with an increased mortality. Intermittent fasting and ketogenesis have been shown to be beneficial for maintaining a circadian rhythm and initiating anti-inflammatory repair mechanisms which could potentially be neuroprotective. However, so far there is little data if cyclic enteral feeding with ketogenic nighttime fasting might be beneficial for reducing the rate of postoperative delirium. The study hypothesis is that equicaloric cyclic enteral feeding (12 hrs) during daytime with ketogenic fasting and exogenous ketone supplementation at nighttime compared to continuous standard enteral nutrition (24 hours) decreases the incidence of postoperative delirium in critically ill patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Postoperative delirium remains a common postoperative problem in critically ill patients with a prevalence of up to 20% and even up to 50% in the elderly population. But postoperative delirium has a negative impact on mortality as several studies were able to show in the past. Therefore, aiming for a reduction of postoperative delirium has an important impact on patients' outcome. One helpful tool for avoiding postoperative delirium is maintaining a circadian pattern. Enteral feeding may play an important role here. Healthy humans have a circadian feeding pattern with nighttime fasting. There is increasing evidence that a circadian rhythm of feeding (cyclic feeding) could be beneficial for critical ill patients. Cyclic feeding and fasting are assumed to have positive effects on the gut microbiome resulting in optimization of host responses to gastrointestinal pathogens. Another positive effect of cyclic feeding potentially results from activation of a "fasting response", inducing repair pathways such as ketogenesis, mitochondrial biogenesis, anti-inflammatory pathways, antioxidant defenses and autophagy processes. The activation of these repair pathways could diminish cellular stress and promote cellular recovery in critical ill patients. This could have a positive effect on postoperative delirium. A randomized controlled trial by van Dyck et al. could show that fasting-mimicking intervals of 12 hours are sufficient to generate a metabolic fasting response without risking a caloric deficit. This fasting response can be enhanced by additional supplementation of exogenous ketones. The study objective is that equicaloric cyclic enteral feeding (for 12 hours) during daytime with ketogenic fasting (for 12 hours) at nighttime (aiming for a ß-hydroxybutyrate blood concentrations ≥ 0.5mM by exogenous ketone supplementation) compared to continuous (for 24 hours) standard enteral nutrition as per patients' nutritional requirements decreases the incidence of postoperative delirium of critically ill patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Delirium Ketogenic Dieting Nutrition, Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Prospective, randomized, monocentric, interventional study
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

sealed, opaque envelopes

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Interventional group: Cyclic enteral nutrition with ketogenic nighttime fasting

Interventional group: Cyclic enteral daytime nutrition (12 hours) with ketogenic nighttime fasting (12 hours) with supplementation of exogenous ketones (ß-hydroxybutyrate) in the Intensive Care Setting.

Group Type EXPERIMENTAL

Cyclic enteral daytime feeding with ketogenic nighttime fasting and exogenous ketone salt supplementation (ß-hydroxybutyrate)

Intervention Type DIETARY_SUPPLEMENT

Nighttime fasting and ß-hydroxybutyrate supplementation

Control group: Conventional continuous enteral nutrition

Continuous (24 hours) enteral nutrition in the Intensive Care Setting.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cyclic enteral daytime feeding with ketogenic nighttime fasting and exogenous ketone salt supplementation (ß-hydroxybutyrate)

Nighttime fasting and ß-hydroxybutyrate supplementation

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

cyclic nutrition with nighttime fasting and exogenous ß-hydroxybutyrate supplementation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years
* Admission to an ICU
* Start of enteral nutrition

Exclusion Criteria

* Severe liver insufficiency / liver disease (Child Pugh \> B or 7-9 points)
* Post total Pancreatectomy / Insulin-depending diabetes mellitus (IDDM)
* Pregnancy / Lactation
* Hemoglobin-concentration \< 80g/l
* Severe metabolic disorder / severe autoimmune disease
* Refractory respiratory or metabolic acidosis
* Disorder of mitochondrial transportation of fatty acids
* Disorder of the oxidation of fatty acids
* Disorder of gluconeogenesis, der ketone body production or ketone body degradation
* Intermittent porphyria
* Severe arrhythmia / cardiomyopathy
* Contraindications against enteral nutrition
* Missing informed consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital of Cologne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sandra Emily Stoll

MD, Ass. Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bernd W Böttiger, Prof

Role: STUDY_DIRECTOR

University Hospital Cologne

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sandra E Stoll, MD, assProf.

Role: CONTACT

+49221478 ext. 82054

Fabian Dusse, PD, MD

Role: CONTACT

+49221478 ext. 40806

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

22-1398_2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Dexamethasone and Postoperative Delirium
NCT02109081 TERMINATED PHASE4